Hypercortisolism induces a state of insulin resistance that can occur concurrently with fasting hyperglycaemia, dyslipidaemia and diabetes mellitus. Metformin reduces hepatic glucose production and insulin resistance of the skeletal muscle and adipose tissue. The aim of this study was to evaluate the effects of metformin on the control of metabolic disorders of dogs with hyperadrenocorticism (HAC). Twenty-three dogs with HAC were randomly divided into two groups, consisting of a control group and a metformin group (10 mg metformin/kg/12 h). Both groups received the same treatment for HAC. At baseline and 3 months, blood glucose, total cholesterol, triglyceride and insulin concentrations, in addition to urinary cortisol:creatinine ratio, Homeostatic Model Assessment (HOMA) for insulin sensitivity and Î²-cell function were measured. Dogs treated with metformin showed significantly reduced glycaemia, cholesterolaemia and triglyceridaemia. They also presented reduced hyperinsulinism and insulin resistance, as well as improved pancreatic Î²-cell function. The implementation of metformin as an adjuvant therapy is effective for the normalisation of metabolic disorders of dogs with HAC.
metfomin, hyperadrenocorticism, insulin resistance, dyslipidaemia
Synthesis of enhanced corrosion resistant Fe-B-C-Ti amorphous ribbons and evaluation of their photodegradation efficiency under light irradiation.
Zuo M, Moztahida M, Lee DS, Yi S
Chemosphere. 2022; 287(Pt 2): 132175
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
Tak E, Kim M, Cho Y, Choi S, Kim J, Han B, Kim HD, Jang CS, Kim JE, Hong YS, Kim SY, Kim TW
Oncology reports. 2022; 47(1):
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299
Enhancing the flame retardancy and UV resistance of polyamide 6 by introducing ternary supramolecular aggregates.
Li Y, Wang J, Xue B, Wang S, Qi P, Sun J, Li H, Gu X, Zhang S
Chemosphere. 2022; 287(Pt 2): 132100
A UHPLC/MS/MS method for the analysis of active and inactive forms of GLP-1 and GIP incretins in human plasma.
VillaÃ±o D, Zafrilla P, GarcÃa-Viguera C, DomÃnguez-Perles R
Talanta. 2022; 236(): 122806